BrightFocus Foundation - Macular Degeneration New Investigator Grant Program
Event details
| Date | 28.07.2022 |
| Category | Conferences - Seminars |
Aim: BrightFocus provides research funds for researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of age-related macular degeneration. This research grant is intended to support investigators during their early years as an independent investigator involved in studies that have an impact on the causes and/or treatment of macular degeneration.
Duration: 3 years
Funding: $ 450’000
Eligibility: This research grant program is restricted to new and early investigators who have received their MD, PhD or equivalent degree within the past 10 years at the time of application. While BrightFocus designed this award with the intention of supporting investigators who are just starting an independent research career in macular degeneration research who do not have independent grant support, we will consider new scientists who also have new R01 or equivalent grant support if the research proposed is not overlapping with other awards. Applicants may currently be working in a non-profit, governmental, academic research institution, or at a for-profit including start-up and biotech institution.
How to Apply: MDR employs a two-tiered review process in which proposals are first submitted by Letter of Intent. Letters of intent must be submitted through proposalCENTRAL. Instructions for use of the portal can be found here. If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. Reviewers will invite the most enthusiastically reviewed Letters of Intent to submit a full application.
Letter of Intent deadline: 29-July-2020 (11:59 pm EST)
Further information
Duration: 3 years
Funding: $ 450’000
Eligibility: This research grant program is restricted to new and early investigators who have received their MD, PhD or equivalent degree within the past 10 years at the time of application. While BrightFocus designed this award with the intention of supporting investigators who are just starting an independent research career in macular degeneration research who do not have independent grant support, we will consider new scientists who also have new R01 or equivalent grant support if the research proposed is not overlapping with other awards. Applicants may currently be working in a non-profit, governmental, academic research institution, or at a for-profit including start-up and biotech institution.
How to Apply: MDR employs a two-tiered review process in which proposals are first submitted by Letter of Intent. Letters of intent must be submitted through proposalCENTRAL. Instructions for use of the portal can be found here. If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. Reviewers will invite the most enthusiastically reviewed Letters of Intent to submit a full application.
Letter of Intent deadline: 29-July-2020 (11:59 pm EST)
Further information
- More information about the program in general is available here, and about the current call here.
- The application portal can be found here.
- For any other questions, please contact the Research Office.
Practical information
- General public
- Free